The Prognostic Implication of Inflammatory Factor-Based Scoring System in Diffuse Large B-Cell Lymphoma Patients in the Rituximab Era

被引：0
|
作者：
Lee, Ji Hyun
Oh, Sung Yong
Jo, Jae-Cheol
Choi, Yunsuk
Shin, Ho-Jin
Lee, Won-Sik
Kyung, Kwon A.
Lee, Yoojin
Lee, Ho Sup
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4142
引用
收藏
页数：3
相关论文
共 50 条
  • [1] The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era
    T Kobayashi
    J Kuroda
    I Yokota
    K Tanba
    T Fujino
    S Kuwahara
    R Isa
    J Yamaguchi
    E Kawata
    T Akaogi
    H Uchiyama
    H Kaneko
    N Uoshima
    Y Kobayashi
    S Teramukai
    M Taniwaki
    Blood Cancer Journal, 2016, 6 : e383 - e383
  • [2] The Kyoto Prognostic Index for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Kobayashi, Tsutomu
    Kuroda, Junya
    Yokota, Isao
    Tanba, Kazuna
    Taki, Tomohiko
    Fujino, Takahiro
    Kuwahara, Saeko
    Isa, Reiko
    Yamaguchi, Junko
    Kawata, Eri
    Akaogi, Teruaki
    Uchiyama, Hitoji
    Kaneko, Hiroto
    Uoshima, Nobuhiko
    Kobayashi, Yutaka
    Teramukai, Satoshi
    Taniwaki, Masafumi
    BLOOD, 2015, 126 (23)
  • [3] Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era
    Huang, Yu-Chung
    Liu, Chun-Yu
    Lu, Hsueh-Ju
    Liu, Han-Tsung
    Hung, Man-Hsin
    Hong, Ying-Chung
    Hsiao, Liang-Tsai
    Gau, Jyh-Pyng
    Liu, Jin-Hwang
    Hsu, Hui-Chi
    Chiou, Tzeon-Jye
    Chen, Po-Min
    Tzeng, Cheng-Hwai
    Yu, Yuan-Bin
    ANNALS OF HEMATOLOGY, 2013, 92 (11) : 1513 - 1520
  • [4] The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era
    Kobayashi, T.
    Kuroda, J.
    Yokota, I.
    Tanba, K.
    Fujino, T.
    Kuwahara, S.
    Isa, R.
    Yamaguchi, J.
    Kawata, E.
    Akaogi, T.
    Uchiyama, H.
    Kaneko, H.
    Uoshima, N.
    Kobayashi, Y.
    Teramukai, S.
    Taniwaki, M.
    BLOOD CANCER JOURNAL, 2016, 6 : e383 - e383
  • [5] Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era
    Yu-Chung Huang
    Chun-Yu Liu
    Hsueh-Ju Lu
    Han-Tsung Liu
    Man-Hsin Hung
    Ying-Chung Hong
    Liang-Tsai Hsiao
    Jyh-Pyng Gau
    Jin-Hwang Liu
    Hui-Chi Hsu
    Tzeon-Jye Chiou
    Po-Min Chen
    Cheng-Hwai Tzeng
    Yuan-Bin Yu
    Annals of Hematology, 2013, 92 : 1513 - 1520
  • [6] PROPOSAL OF NEW PROGNOSTIC INDEX FOR PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN THE RITUXIMAB ERA
    Yoon, S.
    Yoon, D. H.
    Kim, S.
    Lee, K.
    Kang, E. H.
    Lee, S. W.
    Park, C. J.
    Park, C. S.
    Huh, J.
    Suh, C.
    HAEMATOLOGICA, 2015, 100 : 403 - 404
  • [7] Proposal of New Prognostic Index for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Yoon, Shinkyo
    Yoon, Dok Hyun
    Kim, Shin
    Lee, Kyoungmin
    Kang, Eun Hee
    Lee, Sang-wook
    Park, Chan-Jeoung
    Park, Chan-Sik
    Huh, Jooryung
    Suh, Cheolwon
    BLOOD, 2014, 124 (21)
  • [8] Novel prognostic scoring system for diffuse large B-cell lymphoma
    Zhao, Pan
    Zang, Li
    Zhang, Xiaoying
    Chen, Yafang
    Yue, Zhijie
    Yang, Hongliang
    Zhao, Haifeng
    Yu, Yong
    Wang, Yafei
    Zhao, Zhigang
    Zhang, Yizhuo
    Wang, Xiaofang
    ONCOLOGY LETTERS, 2018, 15 (04) : 5325 - 5332
  • [9] Serum B-cell activating factor (BAFF) in diffuse large B-cell lymphoma: Its prognostic significance in the rituximab era
    Kim, Seok Jin
    Sung, Hwa Jung
    Choi, Chul Won
    Kim, In Sun
    Kim, Byung Soo
    Yoon, Soo-Young
    Won, Jong-Ho
    Kim, Jun Suk
    BLOOD, 2007, 110 (11) : 470A - 471A
  • [10] Prognostic Significance of EBV Association in Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Niitsu, Nozomi
    Takahashi, Naoki
    Yoshino, Tadashi
    Okamoto, Masataka
    Nakamura, Shigeo
    BLOOD, 2015, 126 (23)
12345